GenEng News  Oct 11  Comment 
Takeda Pharmacetical will partner with Crescendo Biologics to develop Humabody ® cancer treatments through a collaboration that could generate up to $790 million for Crescendo. Crescendo will use its proprietary transgenic platform and...
FierceBiotech  Oct 10  Comment 
In the midst of an R&D shift, Takeda inks $790M cancer collab with Crescendo badams Mon, 10/10/2016 - 09:03
MarketWatch  Oct 10  Comment 
Takeda Pharmaceutical Company Limited and Crescendo Biologics Limited said early Monday they entered into a cancer drug development partnership worth up to $36 million and as much as $754 million in additional milestone payments. The...
FiercePharma  Oct 5  Comment 
Takeda's digital innovation 'Shark Tank' challenge yields creative help for depression bbulik Tue, 10/04/2016 - 23:51
FiercePharma  Sep 27  Comment 
Takeda aims to continue Entyvio's sales drive with IBD wearable tech program chelfand Tue, 09/27/2016 - 15:17
FiercePharma  Sep 20  Comment 
As India's Chikungunya epidemic spreads, Zydus and Takeda partner on search for a vaccine phil Tue, 09/20/2016 - 08:40
Japan Today  Sep 14  Comment 
Takeda Pharmaceutical Co Ltd, Japan's leading drug maker, is ready to spend as much as $15 billion for possible acquisitions in a bid to expand its business in the United States, the Financial Times reported Wednesday. The fund will be used...
FierceBiotech  Sep 14  Comment 
Takeda sets aside $15B for U.S. buys after topsy-turvy R&D week: FT badams Wed, 09/14/2016 - 04:10


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki